INTERSTITIAL LUNG DISEASE (ILD)
Clinical trials for INTERSTITIAL LUNG DISEASE (ILD) explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE (ILD) trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE (ILD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to ease lung pressure in scarred lungs
Disease control Recruiting nowThis study tests whether adding a new inhaled drug, mosliciguat, to an existing treatment (treprostinil) is safe for people with high blood pressure in the lungs caused by lung scarring. About 20 adults with this condition will receive the combination and be monitored for side ef…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 17, 2026 04:36 UTC
-
Could a Plant-Based pill help lung scarring in autoimmune patients?
Disease control Recruiting nowThis study tests whether tetrandrine tablets can improve lung function in adults with connective tissue disease-related interstitial lung disease (a type of lung scarring). About 100 participants will receive either tetrandrine or a placebo, on top of their usual medications, for…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: PHASE4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Lung transplant study tests best way to use Heart-Lung machine
Disease control Recruiting nowThis study looks at two ways of using a heart-lung machine (ECMO) during lung transplants: using it for every patient or only when needed. The goal is to find out which method leads to fewer complications and better recovery. About 218 adults getting a lung transplant will take p…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
Robot vs. doctor: which lung biopsy method gives a clearer diagnosis?
Diagnosis Recruiting nowThis study tests whether using a robot to guide a lung biopsy helps doctors get a clearer diagnosis for interstitial lung disease (ILD) compared to the standard method. About 30 adults with suspected ILD will be randomly assigned to one of two biopsy techniques. The goal is to se…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: University of Zurich • Aim: Diagnosis
Last updated May 17, 2026 04:33 UTC
-
AI reads your Heart's electrical signals to catch a silent killer
Diagnosis Recruiting nowThis study tests whether an artificial intelligence (AI) tool can analyze a simple ECG to detect undiagnosed pulmonary hypertension (high blood pressure in the lungs) in people with interstitial lung disease. About 900 adults with severe lung scarring will be randomly assigned to…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Tempus AI • Aim: Diagnosis
Last updated May 17, 2026 04:14 UTC
-
One-Stop shop for lung care: new trial aims to cut patient burden
Symptom relief Recruiting nowThis study tests a new way to organize follow-up care for people with interstitial lung disease (ILD). Instead of making several separate trips for tests, lab work, and doctor visits, the new approach bundles everything into one coordinated hospital visit. The goal is to reduce t…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Symptom relief
Last updated May 17, 2026 04:32 UTC
-
Minty fresh breath: l-menthol tested as a new way to fight lung disease breathlessness
Symptom relief Recruiting nowThis study tests whether L-menthol, a minty compound, can reduce breathlessness and help people with interstitial lung disease (ILD) exercise longer. Twenty adults with ILD will try L-menthol and a placebo in random order to compare effects. The goal is to find a simple, safe way…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: PHASE2 • Sponsor: Region Skane • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
Home checkups could cut clinic visits in half for lung disease patients
Knowledge-focused Recruiting nowThis study looks at whether people with pulmonary fibrosis can use home monitoring and video calls instead of half their regular clinic visits. The goal is to see if this helps patients manage their own health better. About 220 adults with pulmonary fibrosis will take part, and r…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
New study aims to cut lung disease diagnosis time in half
Knowledge-focused Recruiting nowThis study tests whether bundling key tests (like CT scans and lung function tests) into a single, fast-tracked appointment can help people with suspected interstitial lung disease get a diagnosis sooner. About 92 adults will be randomly assigned to either the usual step-by-step …
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
New inhaled drug RJ026 enters first human safety tests for lung scarring
Knowledge-focused Recruiting nowThis early-stage study tests a single inhaled dose of RJ026 in 42 healthy volunteers and 42 people with interstitial lung disease (ILD), a type of lung scarring. The goal is to measure how much drug gets into the blood and lungs, and to check for side effects over 7 days. No trea…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: PHASE1 • Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC